D
Rocket Pharmaceuticals, Inc. RCKT
$3.78 $0.092.44% NASDAQ
Recommendation
Prev Close
$3.78
Volume
9,203
Avg Vol (90D)
2,371,445
Market Cap
$409.08M
Dividend & Yield
--
52-Week Range
$2.19 - $11.45
P/E (TTM)
--
EPS (TTM)
-$2.25
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Rocket Pharmaceuticals (RCKT, $3.64) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 20, 2026
1/21/2026 - Tickeron - Technical Analysis
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Crosses Above Fifty Day Moving Average - Here's Why
1/16/2026 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN) and Rocket Pharmaceuticals (RCKT)
1/15/2026 - TipRanks Financial Blog
Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
1/15/2026 - GuruFocus
Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
1/14/2026 - Seeking Alpha: Transcripts
Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
1/14/2026 - SeekingAlpha
3 cheap stocks that could turn $1,000 into $10,000
1/14/2026 - Finbold Stock News
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Hold" from Analysts
1/13/2026 - Ticker Report
Rocket Pharmaceuticals (RCKT, $3.73) RSI Indicator left the overbought zone on January 09, 2026
1/10/2026 - Tickeron - Stocks
Rocket Pharmaceuticals (RCKT, $3.89) price may drop as it broke higher Bollinger Band on Jan 07, 2026
1/8/2026 - Tickeron - Stocks
Rocket Pharmaceuticals price target lowered by $2 at Morgan Stanley, here's why
1/8/2026 - The Fly
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of "Hold" from Analysts
1/8/2026 - MarketBeat
Video: Wednesday 1/7 Insider Buying Report: CASY, RCKT
1/7/2026 - Market News Video
Rocket Pharmaceuticals (RCKT, $3.55) Stochastic Oscillator left the overbought zone on January 05, 2026
1/6/2026 - Tickeron - Stocks
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
1/5/2026 - GuruFocus
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
1/5/2026 - Business Wire
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Cross Below 50 Day Moving Average - Should You Sell?
12/31/2025 - MarketBeat
Rocket Pharmaceuticals (RCKT, $3.48) Stochastic Oscillator left the overbought zone on December 29, 2025
12/30/2025 - Tickeron - Stocks
Rocket Pharmaceuticals (RCKT, $3.48) entered Uptrend as Momentum indicator ascends above 0 level on Dec 26, 2025
12/27/2025 - Tickeron - Stocks
Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program
12/26/2025 - Seeking Alpha - Long Ideas
Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program
12/26/2025 - SeekingAlpha
Rocket Pharmaceuticals (RCKT, $3.51) entered Downtrend as Momentum indicator drops below 0 level on Dec 24, 2025
12/25/2025 - Tickeron - Stocks
Rocket Pharmaceuticals (RCKT, $3.45) Stochastic Oscillator left the oversold zone on December 23, 2025
12/24/2025 - Tickeron - Stocks
Rocket Pharmaceuticals (RCKT, $3.53) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 22, 2025
12/23/2025 - Tickeron - Technical Analysis
Rocket Pharmaceuticals (RCKT, $3.53) entered Uptrend as Momentum indicator ascends above 0 level on Dec 22, 2025
12/23/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$236.01M
EBIT (TTM)
-$247.18M
Net Income (TTM)
-$240.91M
Balance Sheet
Total Assets (Q)
$368.03M
Total Debt (Q)
$25.05M
Total Liabilities (Q)
$54.36M
Book Value Per Share (Q)
$2.90
Cash Flow
Cash from Operations (TTM)
-$202.12M
Cash from Investing (TTM)
$29.47M
Cash from Financing (TTM)
$183.00M
Net Change in Cash (TTM)
$10.35M
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.20
7-Day Total Return
-0.53%
30-Day Total Return
12.50%
60-Day Total Return
-4.06%
90-Day Total Return
17.39%
Year to Date Total Return
9.25%
1-Year Total Return
-65.88%
2-Year Total Return
-86.60%
3-Year Total Return
-81.52%
5-Year Total Return
-93.36%
52-week Low
May 27, 2025 - $2.19
52-week High
Feb 05, 2025 - $11.45
Valuation
Market Cap
$409.08M - Small Cap
Enterprise Value
$211.37M
Price/Sales (TTM)
--
Price/Book (Q)
1.30
Dividends and Shares
Shares Outstanding
111.57M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.rocketpharma.com
Phone Number
609 659 8001
Address
9 Cedarbrook Drive
Cranbury, NJ 08512
Country
United States
Year Founded
1999
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the... more
NASDAQ 01/22/2026 4:00PM Eastern Quotes delayed